Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine PK in Breast Milk
NCT04285684Phase 1Completed
- Sponsor
- Ketamine Research Foundation
- Start
- Dec 2019
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ketamine in postpartum depression (PPD), sponsored by Ketamine Research Foundation. Primary endpoints: Ketamine Concentration in Breast Milk at 30 hours, Norketamine Concentration in Breast Milk at 30 hours and 2 more. Started Dec 2019; status: completed.
02
Drugs
ketamine
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT04285684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04285684.